Targanta Therapeutics is a biopharma Company
Business Model:
Revenue: $0
Employees: 51-200
Targanta Therapeutics was acquired by
The Medicines Company.
The acquisition happend on 2009-01-13.
Details of the transaction were not public
Address:
City: Cambridge
State: Massachusetts
Zip:
Country: United States
Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious infections treated or acquired in hospitals and other institutional settings.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/10/2007
Ticker Symbol:
TARG
IPO Price:
$10/share
Amount Raised:
$58M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2007 | Series C | 4 | $70M |
OrbiMed Brookside Capital Skyline Ventures Radius Ventures OrbiMed Brookside Capital Skyline Ventures Radius Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|